SEC Form 4 · accession 0001493152-16-014599
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO and EVP
Period of report
Nov 4, 2016
Accepted (ET)
Nov 7, 2016 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 4, 2016 | A | 26,000 | $6.64 | A | 27,910 | D | |
| Common StockF1 | Nov 4, 2016 | A | 1,750 | $6.64 | A | 29,660 | I | See Footnote |
| Common StockF2 | Nov 4, 2016 | A | 1,750 | $6.64 | A | 31,410 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As custodian of Minor Child 1.
- F2As custodian of Minor Child 2.